Meta Information

ID:boswellia

Name:Boswellia

Schema Version:1.5

Title

Boswellia

Alternate Names

• Indian Frankincense
• Boswellia serrata

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

15

High Cost:

40

Cost Type:

monthly

Description:

Cost for a 30-day supply of standardized Boswellia serrata extract.

Summary

Boswellia, derived from the Boswellia serrata tree, primarily functions by inhibiting the pro-inflammatory enzyme 5-lipoxygenase (5-LOX), thereby reducing the production of leukotrienes. Its relevance to healthspan lies in its ability to manage chronic, low-grade inflammation ('inflammaging'), a core driver of aging. By mitigating inflammatory pathways, it supports joint health, gut integrity, and potentially reduces systemic inflammation.

Purpose

A natural anti-inflammatory that targets joint health and systemic inflammation.

Card Summary

Natural anti-inflammatory for joint health and managing inflammaging.

Drug Class

Drugs In Class

Empty Array

Impact

Score:

4.5

Justification:

Effective for targeted inflammation (e.g., joints), with less evidence for systemic longevity benefits.

Evidence

Grade:

A

Score:

8

Justification:

Multiple human RCTs and meta-analyses confirm efficacy for osteoarthritis and inflammatory conditions.

Safety

Score:

3

Justification:

Generally well-tolerated with mild, infrequent gastrointestinal side effects reported in studies.

Flags

• May interact with antiplatelet/anticoagulant drugs (e.g., warfarin) and NSAIDs.
• Look for extracts standardized to at least 30% boswellic acids, particularly AKBA.
• Potential for mild gastrointestinal side effects like nausea or acid reflux.

Verdict

A well-evidenced supplement for managing joint inflammation and pain.

Created

2026-04-23T22:57:09.293740Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:

oral

Scope:

• systemic

Indication

Focus:

healthspan

Description:

Boswellia, derived from the Boswellia serrata tree, primarily functions by inhibiting the pro-inflammatory enzyme 5-lipoxygenase (5-LOX), thereby reducing the production of leukotrienes. Its relevance...

Typical Protocol

• Take 300-500 mg of standardized extract (30-65% boswellic acids) two to three times daily.